Bionano Genomics, Inc. 10-Q filing
Filed 2026-05-13 · Report date 2026-03-31 · 2026
Filing metadata
- Accession number
- 0001411690-26-000028
- Form type
- 10-Q
- CIK
- 0001411690
- Primary document
- https://www.sec.gov/Archives/edgar/data/1411690/000141169026000028/bngo-20260331.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bionano Genomics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $6.7M | - | - |
| Cost Of Revenue | $3.4M | - | - |
| Operating Income | $-7.9M | - | - |
| Net Income | $-8.3M | - | - |
| Eps Basic | -0.76 | - | - |
| Eps Diluted | -0.76 | - | - |
| Cash And Equivalents | $3.4M | - | - |
| Total Assets | $64.8M | - | - |
| Total Liabilities | $27.3M | - | - |
| Shareholders Equity | $37.5M | - | - |
| Operating Cash Flow | $-5.7M | - | - |